Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Speakers’ Corner 1: AMD Session

Date/Time: | Room:

Back to Previous



10:45:00 C. Yasar Turkey Vitamin D and optical coherence tomography in neovascular age-related macular degeneration
10:50:00 S. Kim Korea, South A Nationwide Incidence of clinical exudative neovascular age-related macular degeneration under real-world medical system of South Korea and related injection use during 2010-2015
10:55:00 G. Tsokolas United Kingdom Use of intravitreal (IVI) bevacizumab for the treatment of choroidal neovascular membrane secondary to Sorsby fundus dystrophy
11:00:00 Y. Toklu Turkey Evaluation of ocular blood flow with color doppler ultrasonography after intravitreal aflibercept injection
11:05:00 F. Bandello Italy Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: Twelve-month results of the TWEYEs study
11:10:00 L. Chang China One-year results of intravitreal conbercept therapy between two different angiographic subtypes of polypoidal choroidal vasculopathy
11:15:00 C. Lee Korea, South Long-term incidence and growth of chorioretinal atrophy in patients with polypoidal choroidal vasculopathy
11:20:00 S. Joseph United Kingdom A clinical evaluation of efficacy of stereotactic radiotherapy in reducing the frequency of anti –VEGF injections in wet AMD
11:25:00 A. Daly Ireland A Global Coalition of patient organisations collaborated to develop a multi stakeholder educational toolkit to improve education and outcomes of age-related macular degeneration – AMD
11:30:00 R. Crosby-Nwaobi United Kingdom Complete audit cycle on loading phase of aflibercept for treatment naive neovascular age-related macular degeneration (nAMD)
11:35:00 L. Raja United Kingdom One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital
11:40:00 A. Hobby United Kingdom Association between number of injections during long-term anti VEGF therapy and retinal electrophysiological parameters
11:45:00 T. Rauchegger Austria Effectiveness of aflibercept in exudative age-related macular degeneration: Real-Life Data Study Innsbruck
11:50:00 C. Yun Korea, South Variations in chorioretinal vasculatures in patients with age-related macular degeneration
11:55:00 I. Jamiołkowska Poland Analysis of choroidal thickness changes in patients with exudative age‑related macular degeneration treated with aflibercept
12:00:00 T. Koutresi United Kingdom Novel phenotypic association of Sorsby fundus dystrophy with with polypoidal choroidal vasculopathy

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved